Clinical Trial Update: Prediction of Ovarian Malignancy in the Presence of Sonographic Pelvic Mass

View source ↗

Summary

A clinical trial evaluating the prediction of ovarian malignancy in the presence of a sonographic pelvic mass has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Ovarian Neoplasm | Status: WITHDRAWN